These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 4458842)

  • 1. Hypotensive and vasodilator actions of SK&F 24260, a new dihydropyridine derivative.
    Fielden R; Owen DA; Taylor EM
    Br J Pharmacol; 1974 Nov; 52(3):323-32. PubMed ID: 4458842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemodynamic profile of a new antihypertensive agent D,L-3-[2-(3-t-butylamino-2-hydroxypropoxy)phenyl]-6-hydrazinopyridazine (SK&F 92657).
    Taylor EM; Cameron D; Eden RJ; Fielden R; Owen DA
    J Cardiovasc Pharmacol; 1981; 3(2):337-54. PubMed ID: 6166805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SK & F 95018, a vasodilator/beta-adrenoceptor antagonist.
    Swayne GT; Owen DA; Taylor EM; Eden RJ; Slater RA; Howson W
    Arch Int Pharmacodyn Ther; 1987 Oct; 289(2):251-66. PubMed ID: 2892473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo pharmacological studies with SK&F 94836, a potent inotrope/vasodilator with a sustained duration of action.
    Gristwood RW; Comer MB; Eden RJ; Taylor EM; Turner JA; Wallduck M; Owen DA
    Br J Pharmacol; 1988 Apr; 93(4):893-901. PubMed ID: 3390657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of the coronary vasodilator action of SK&F 24260 in the dog.
    Narimatsu A; Satoh K; Taira N
    Clin Exp Pharmacol Physiol; 1978; 5(2):107-15. PubMed ID: 648031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of radioactive microspheres to compare the effects of hydralazine, guanethidine and SK & F 24260 on the redistribution of cardiac output in anaesthetized rabbits.
    Johnson BM
    Br J Pharmacol; 1975 Nov; 55(3):393-402. PubMed ID: 1134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypotensive and regional hemodynamic effects of the dopamine receptor agonist SK & F 85174 in the anesthetized rat.
    Van der Niepen P; Schoors DF; Dupont AG
    Arch Int Pharmacodyn Ther; 1991; 313():98-107. PubMed ID: 1687774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the antihypertensive activity of SK&F 86466, a selective alpha-2 antagonist, in the rat.
    Roesler JM; McCafferty JP; DeMarinis RM; Matthews WD; Hieble JP
    J Pharmacol Exp Ther; 1986 Jan; 236(1):1-7. PubMed ID: 2867209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coronary circulation systemic resistance and capacitance blood vessels of dogs as affected by BAY a 1040.
    Hirakawa S; Ito H; Kondo Y; Watanabe I; Hiei K
    Arzneimittelforschung; 1972 Feb; 22(2):344-9. PubMed ID: 4623698
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies on the mechanism of the acute antihypertensive and vasodilator actions of several beta-adrenoceptor antagonists.
    Sybertz EJ; Baum T; Pula KK; Nelson S; Eynon E; Sabin C
    J Cardiovasc Pharmacol; 1982; 4(5):749-58. PubMed ID: 6182405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular effects of a novel vasoactive antihypertensive agent, Ro 12-4713.
    Gerold M; Eigenmann R; Hefti F; Daum A; Haeusler G
    J Pharmacol Exp Ther; 1981 Mar; 216(3):624-33. PubMed ID: 7009831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of NG-nitro-L-arginine methyl ester on vasodilator responses to adrenaline or BRL 38227 in conscious rats.
    Gardiner SM; Kemp PA; Bennett T
    Br J Pharmacol; 1991 Nov; 104(3):731-7. PubMed ID: 1797333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cardiovascular pharmacology of ICI 170777 ((6RS)-6-methyl-5-(pyrid-4-yl)-3H,6H-1,3,4- thiadiazin-2-one) a novel compound with positive inotropic and vasodilator effects.
    Collis MG; Keddie JR; Rouse W
    Br J Pharmacol; 1989 Jun; 97(2):409-18. PubMed ID: 2758224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of beta 2-receptor stimulation in the peripheral vascular actions of the antihypertensive dilevalol.
    Watkins RW; Sybertz EJ; Cook J; Pula K; Cedeno K; Tedesco RP; McLeod R
    Arch Int Pharmacodyn Ther; 1989; 302():158-73. PubMed ID: 2576892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological studies of N-(2,5-dimethyl-1H-pyrrol-1-yl)-6-(4-morpholinyl)-3-pyridazinamine hydrochloride (MDL-899), a new long-acting antihypertensive vasodilator.
    Baldoli E; Bianchi G; Corsico N; Di Francesco GF
    Arzneimittelforschung; 1985; 35(5):818-26. PubMed ID: 2862874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacology of 4-(2'-nitrophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylic acid dimethyl ester (Nifedipine, BAY a 1040)].
    Vater W; Kroneberg G; Hoffmeister F; Saller H; Meng K; Oberdorf A; Puls W; Schlossmann K; Stoepel K
    Arzneimittelforschung; 1972 Jan; 22(1):1-14. PubMed ID: 4622472
    [No Abstract]   [Full Text] [Related]  

  • 17. Characterization of the peripheral and central effects of SK&F 82526, a novel dopamine receptor agonist.
    Hahn RA; Wardell JR; Sarau HM; Ridley PT
    J Pharmacol Exp Ther; 1982 Nov; 223(2):305-13. PubMed ID: 6127401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological studies with SK&F 94120, a novel positive inotropic agent with vasodilator activity.
    Gristwood RW; Eden RJ; Owen DA; Taylor EM
    J Pharm Pharmacol; 1986 Jun; 38(6):452-9. PubMed ID: 2873222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Further characterization of the cardiovascular effects of the dopamine beta-hydroxylase inhibitor SK&F 102698 in conscious hypertensive rats.
    Ohlstein EH; Kruse LI; Ezekiel M; Willette RN
    J Pharmacol Exp Ther; 1988 Oct; 247(1):186-95. PubMed ID: 3050029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiohemodynamic effects of SK&F 24260, D 600, diltiazem, dilazep, and trimetazidine in the dog.
    Imai Y; Himori N; Taira N
    Jpn Heart J; 1977 Jan; 18(1):120-31. PubMed ID: 846043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.